With continuous glucose monitoring systems (CGM) become more insurance covered, more affordable and better accuracy, more and more diabetic patients are using glucose CGM because of its great benefits,
Glutalor Medical announces one of its US patent applications related to its glucose CGM (continuous glucose monitoring) technology has been granted. Their patent application ” Dynamic Blood Glucose Data Acquiring Device and Host” was granted Read more…
Glutalor Medical announces one of its EU Patent applications related to its glucose CGM (continuous glucose monitoring) technology has been granted. Their patent application ” CONTINUOUS GLUCOSE MONITORING SYSTEM AND MONITORING TERMINAL” was granted in Read more…
0 Comments